Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.3 USD | +0.97% | +2.72% | -27.45% |
Business Summary
Number of employees: 267
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Collaborative Arrangements
100.0
%
| 411 | 100.0 % | 443 | 100.0 % | +7.83% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 411 | 100.0 % | 443 | 100.0 % | +7.83% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas McCourt
CEO | Chief Executive Officer | 66 | 08-12-31 |
Sravan Emany
DFI | Director of Finance/CFO | 46 | 21-12-05 |
Marcel Moulaison
CTO | Chief Tech/Sci/R&D Officer | - | 13-12-31 |
Chief Tech/Sci/R&D Officer | 65 | 19-01-27 | |
Greg Martini
IRC | Investor Relations Contact | - | 17-05-31 |
Susanna H. Huh
PRN | Corporate Officer/Principal | - | 22-08-31 |
Mike Nanfito
SAM | Sales & Marketing | - | 12-04-30 |
John Minardo
LAW | General Counsel | 49 | 21-08-02 |
Ronald Silver
AUD | Comptroller/Controller/Auditor | 42 | 18-05-31 |
Andrew Davis
PRN | Corporate Officer/Principal | 38 | 21-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alexander Denner
BRD | Director/Board Member | 54 | 20-11-08 |
Jay Shepard
BRD | Director/Board Member | 66 | 20-12-02 |
Mark Currie
BRD | Director/Board Member | 69 | 19-12-31 |
Andrew Dreyfus
BRD | Director/Board Member | 65 | 16-03-31 |
Thomas McCourt
CEO | Chief Executive Officer | 66 | 08-12-31 |
Director/Board Member | 64 | 19-03-31 | |
Julie McHugh
CHM | Chairman | 59 | 14-01-31 |
Jon Duane
BRD | Director/Board Member | 65 | 19-03-31 |
Marla Kessler
BRD | Director/Board Member | 54 | 19-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 10 | 158,957,123 | 156,204,549 ( 98.27 %) | 0 | 98.27 % |
Company contact information
Ironwood Pharmaceuticals, Inc.
100 Summer Street Suite 2300
02110, Boston
+617 621 7722
http://www.ironwoodpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.45% | 1.31B | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- IRWD Stock
- Company Ironwood Pharmaceuticals, Inc.